Yan-Hong Li

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Ulcerative Colitis

Multiple Sclerosis

Binding Protein

Top Venues

Journal of natural products

Chinese medicine

Expert opinion on pharmacotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Li-Rong Deng, Qian Han, Min Zou, Fang-Jun Chen, Chang-Yin Huang, Yi-Ming Zhong, Qian-Yan Wu, Brian Tomlinson, Yan-Hong Li
Identification of potential immunomodulators from Pulsatilla decoction that act on therapeutic targets for ulcerative colitis based on pharmacological activity, absorbed ingredients, and in-silico molecular docking. Chinese medicine 17 (1) (2022)
Christopher Wai Kei Lam, Yan-Hong Li, Paul Chan
Evaluating gliclazide for the treatment of type 2 diabetes mellitus. Expert opinion on pharmacotherapy 23 (17) (2022)
Qian Han, Hua-Zheng Tang, Min Zou, Jie Zhao, Ling Wang, Zhao-Xiang Bian, Yan-Hong Li
Correction to Anti-inflammatory Efficacy of Combined Natural Alkaloid Berberine and S1PR Modulator Fingolimod at Low Doses in Ulcerative Colitis Preclinical Models. Journal of natural products 84 (8) (2021)
Qian Han, Hua-Zheng Tang, Min Zou, Jie Zhao, Ling Wang, Zhao-Xiang Bian, Yan-Hong Li
Anti-inflammatory Efficacy of Combined Natural Alkaloid Berberine and S1PR Modulator Fingolimod at Low Doses in Ulcerative Colitis Preclinical Models. Journal of natural products 83 (6) (2020)